Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Larson

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 21, 2019
Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 InhibitorsPamela J Farrell, Christopher J Zopf, Huey-Jing Huang, et al.
Molecular Metabolism|December 17, 2018
CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO miceMatthew Riopel, Melanie Vassallo, Erik Ehinger, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
'Reverse' alpha-ketoamide-based p38 MAP kinase inhibitorsAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
European Journal of Pharmacology|February 6, 2010
KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinaseAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
BMC Medical Education|February 11, 2021
Correction to: Understanding the key processes of excellence as a prerequisite to establishing academic centres of excellence in AfricaAbebaw Fekadu, Claire Oppenheim, Tsegahun Manyazewal, et al.
The Journal of Clinical Investigation|March 6, 2018
Chronic fractalkine administration improves glucose tolerance and pancreatic endocrine functionMatthew Riopel, Jong Bae Seo, Gautam K Bandyopadhyay, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2008
The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitorsAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
BMC Medical Education|January 8, 2021
Understanding the key processes of excellence as a prerequisite to establishing academic centres of excellence in AfricaAbebaw Fekadu, Claire Oppenheim, Tsegahun Manyazewal, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
Optimization of alpha-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric siteAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Circulation. Heart Failure|May 12, 2016
Developing New Treatments for Heart Failure: Focus on the HeartMihai Gheorghiade, Christopher J Larson, Sanjiv J Shah, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|September 21, 2019
Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 InhibitorsPamela J Farrell, Christopher J Zopf, Huey-Jing Huang, et al.
Molecular Metabolism|December 17, 2018
CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO miceMatthew Riopel, Melanie Vassallo, Erik Ehinger, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
'Reverse' alpha-ketoamide-based p38 MAP kinase inhibitorsAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
European Journal of Pharmacology|February 6, 2010
KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinaseAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
BMC Medical Education|February 11, 2021
Correction to: Understanding the key processes of excellence as a prerequisite to establishing academic centres of excellence in AfricaAbebaw Fekadu, Claire Oppenheim, Tsegahun Manyazewal, et al.
The Journal of Clinical Investigation|March 6, 2018
Chronic fractalkine administration improves glucose tolerance and pancreatic endocrine functionMatthew Riopel, Jong Bae Seo, Gautam K Bandyopadhyay, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2008
The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitorsAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
BMC Medical Education|January 8, 2021
Understanding the key processes of excellence as a prerequisite to establishing academic centres of excellence in AfricaAbebaw Fekadu, Claire Oppenheim, Tsegahun Manyazewal, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
Optimization of alpha-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric siteAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Circulation. Heart Failure|May 12, 2016
Developing New Treatments for Heart Failure: Focus on the HeartMihai Gheorghiade, Christopher J Larson, Sanjiv J Shah, et al.
Pageof 4